OP0020 Identification of Multiple Sjögren’s Syndrome Susceptibility Loci

  title={OP0020 Identification of Multiple Sj{\"o}gren’s Syndrome Susceptibility Loci},
  author={Christopher J. Lessard and Hongliang Li and John A. Ice and Indra Adrianto and Roland Jonsson and Gabor G. Illei and Maureen Rischmueller and Gunnel Nordmark and Xavier Mariette and Corinne Miceli-Richard and M. Wahren Herlenius and Torsten Witte and Michael T. Brennan and Roald Omdal and Patrick M Gaffney and James A. Lessard and Lars R{\"o}nnblom and W. F. Ng and Nelson L. Rhodus and B. Segal and Robert Hal Scofield and Judith A. James and Juan-Manuel Anaya and Courtney G. Montgomery and John B Harley and Kathy L. Moser Sivils},
  journal={Annals of the Rheumatic Diseases},
  pages={A54 - A55}
Background Sjögren’s syndrome (SS) is a common, clinically heterogeneous autoimmune disease characterized by exocrine gland dysfunction that involves both innate and adaptive immune responses. A complex genetic architecture has been hypothesized; however, genetic studies to date have been limited to candidate gene approaches. Objectives We sought to perform the first genome-wide association scan (GWAS) in an unbiased manner to identify SS risk loci. Methods We used high-density Illumina OMNI1… 
Advances in understanding the pathogenesis of primary Sjögren's syndrome
Recent findings regarding the pathogenic mechanisms involved in primary Sjögren's syndrome are summarized and lead to the development of promising novel therapeutic strategies.
Behçet's syndrome: pulmonary vascular disease
Although the authors now know the condition and its associated complications better, it is needed to study how to predict development of PAI, its pathogenesis and finally what can they do to improve the survival.
Immunogenetics of some connective tissue disorders
Connective tissue diseases (CTDs) are systemic autoimmune disorders characterized by a large spectrum of clinical features and multisystemic involvement. Connective tissue disease is any disease that
Intra-articular corticosteroid for knee osteoarthritis.
The quality of the evidence was graded as 'low' for all outcomes because treatment effect estimates were inconsistent with great variation across trials, pooled estimates were imprecise and did not rule out relevant or irrelevant clinical effects, and most trials had a high or unclear risk of bias.
Mécanismes de la lymphomagenèse au cours des maladies auto-immunes : rôle de la génétique, de l'activité de la maladie et des traitements
Il existe un sur-risque de lymphome dans trois des principales maladies auto immunes (MAI) systemiques : la polyarthrite rhumatoide (PR), le lupus erythemateux systemique (LES) et le syndrome de